HSPA1L and COVID-19: However, based on the in silico analysis and data from COVID-19 patients’ blood samples, we suggest that the HSPA1L could be considered as an epigenetic biomarker for diagnostic stratification of COVID19 patients in a much larger study and could be used as a potential target for to prevent the entry of SARS-CoV-2 virus into the host cells.